TADLIQ
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
46287-045 -
Package NDC
46287-045-15 -
Application number
NDA214522 -
SPL ID
cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93 -
SPL set ID
7a909b25-3772-403e-a5fe-e4a040293fb7 -
UNII
742SXX0ICT -
RxCUI
2613563 -
RxCUI
2613569
What the source publishes
- Labeler
- CMP Pharma, Inc.
- Active ingredients
- Tadalafil
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TADLIQ",
"splId": "cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93",
"labels": [
{
"setId": "7a909b25-3772-403e-a5fe-e4a040293fb7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a909b25-3772-403e-a5fe-e4a040293fb7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a909b25-3772-403e-a5fe-e4a040293fb7"
}
],
"routes": [
"ORAL"
],
"labeler": "CMP Pharma, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "150 mL in 1 BOTTLE (46287-045-15)",
"package_ndc": "46287-045-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20220830"
}
],
"productId": "46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "46287-045",
"deaSchedule": null,
"genericName": "Tadalafil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TADALAFIL",
"strength": "20 mg/5mL"
}
],
"applicationNumber": "NDA214522",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220830",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175599",
"N0000020026"
],
"unii": [
"742SXX0ICT"
],
"rxcui": [
"2613563",
"2613569"
],
"spl_set_id": [
"7a909b25-3772-403e-a5fe-e4a040293fb7"
],
"pharm_class_epc": [
"Phosphodiesterase 5 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Phosphodiesterase 5 Inhibitors [MoA]"
],
"manufacturer_name": [
"CMP Pharma, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93"